Characterization of new polymorphisms in the 5′UTR of the human interleukin-1 receptor type 1 (IL1R1) gene: linkage to type 1 diabetes and correlation to IL-1RI plasma level

被引:0
作者
R Bergholdt
ZM Larsen
NA Andersen
J Johannesen
OP Kristiansen
T Mandrup-Poulsen
J Nerup
F Pociot
机构
[1] Steno Diabetes Center,
[2] The Danish Study Group of IDDM in Childhood.,undefined
[3] The Danish IDDM Epidemiology and Genetics Group. The study was supported by grants from the Danish Medical Research Council (No. 9802011),undefined
[4] EEC (BMH-CT97-2311 and BMH4-CT98-3363 (DG12-SSMI)),undefined
[5] The Poul and Erna Sehested-Hansen Foundation and Novo Nordisk A/S. OPK is a recipient of a JDFI fellowship grant (JDFI number 3-1999-21).,undefined
来源
Genes & Immunity | 2000年 / 1卷
关键词
interleukin-1 receptor; polymorphisms; functional genetics; diabetes; PEP-DNA;
D O I
暂无
中图分类号
学科分类号
摘要
The human interleukin-1 type I receptor (IL-1RI) is the signal transducing receptor for IL-1, a principal proinflammatory cytokine, which is cytotoxic to pancreatic islet beta cells. The IL-1RI gene, IL1R1, maps to chromosome 2q12. We have previously examined part of the IL1R1 promoter region and in the present study we further characterized the promoter region demarcating exon 1B and 1C by sequencing and mutation scanning. New sequence was obtained 1762 bp upstream and 1609 bp downstream the known region. Within this sequence, we identified four frequent single nucleotide polymorphisms (SNPs). PCR-based RFLP assays were established and three of the polymorphisms were typed in a Danish Type 1 (insulin-dependent) diabetes mellitus (T1DM) family collection comprising 103 simplex and 150 sib-pair affected families. Linkage was evaluated by the sib-TDT (transmission disequilibrium test). One of the polymorphisms, defined by a HinfI RFLP assay, demonstrated linkage to T1DM, P(sTDT) = 0.026. Random transmission was observed to unaffected offspring from heterozygous parents, P = 0.87. No evidence for positive linkage was seen for the other tested polymorphisms, P = 0.14 and P = 0.21, respectively. To evaluate the possible functional significance of the HinfI polymorphism, we measured circulating IL-1RI plasma level in 30 T1DM patients and in 30 control subjects – 10 with each genotype in both groups. Significant differences in plasma levels in relation to genotype – independent of disease status – were found (P = 0.04). In both diabetic and non-diabetic subjects, the wt/wt genotype correlated with the highest IL-1RI plasma level, whereas the plasma levels were lowest for the mt/mt genotype.
引用
收藏
页码:495 / 500
页数:5
相关论文
共 50 条
  • [41] Evaluation of plasma IL-21 as a potential biomarker for type 1 diabetes progression
    Schroderus, Anna-Mari
    Poorbaugh, Josh
    McElyea, Samantha
    Beasley, Stephanie
    Zhang, Lin
    Nanto-Salonen, Kirsti
    Rintamaki, Reeta
    Pihlajamaki, Jussi
    Knip, Mikael
    Veijola, Riitta
    Toppari, Jorma
    Ilonen, Jorma
    Benschop, Robert J.
    Kinnunen, Tuure
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] Association of polymorphisms in the IL-18 and IL-12 genes with susceptibility to Type 1 diabetes in Turkish patients
    Altinova, A. E.
    Engin, D.
    Akbay, E.
    Akturk, M.
    Toruner, F.
    Ersoy, R.
    Yetkin, I.
    Arslan, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2010, 33 (07) : 451 - 454
  • [43] Gene Variant and Level of IL-1β in Ischemic Stroke Patients With and Without Type 2 Diabetes Mellitus
    Chehaibi, Khouloud
    Hrira, Mohamed Yahia
    Trabelsi, Imen
    Escola-Gil, Juan Carlos
    Slimane, Mohamed Naceur
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2015, 57 (03) : 404 - 409
  • [44] Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece
    Panierakis, Charalambos
    Goulielmos, George
    Mamoulakis, Dimitris
    Petraki, Eleni
    Papavasiliou, Efstathios
    Galanakis, Emmanouil
    CLINICAL IMMUNOLOGY, 2009, 133 (02) : 276 - 281
  • [45] PD-L1 gene polymorphisms and low serum level of PD-L1 protein are associated to type 1 diabetes in Chile
    Pizarro, Carolina
    Garcia-Diaz, Diego F.
    Codner, Ethel
    Salas-Perez, Francisca
    Carrasco, Elena
    Perez-Bravo, Francisco
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (08) : 761 - 766
  • [46] Modulation of virus-induced innate immunity and type 1 diabetes by IL-1 blockade
    Hara, Naoko
    Alkanani, Aimon K.
    Dinarello, Charles A.
    Zipris, Danny
    INNATE IMMUNITY, 2014, 20 (06) : 574 - 584
  • [47] IL-2 therapy in type 1 diabetes: "Trials" and tribulations
    Long, S. Alice
    Buckner, Jane H.
    Greenbaum, Carla J.
    CLINICAL IMMUNOLOGY, 2013, 149 (03) : 324 - 331
  • [48] Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: a combined haplotype analysis
    Kupcinskas, Limas
    Wex, Thomas
    Kupcinskas, Juozas
    Leja, Marcis
    Ivanauskas, Audrius
    Jonaitis, Laimas Virgilijus
    Janciauskas, Dainius
    Kiudelis, Gediminas
    Funka, Konrads
    Sudraba, Agnese
    Chiu, Han-Mo
    Lin, Jaw-Town
    Malfertheiner, Peter
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (10) : 1189 - 1195
  • [49] Association of SGK1 gene polymorphisms with type 2 diabetes
    Schwab, Matthias
    Lupescu, Adrian
    Mota, Maria
    Mota, Eugen
    Frey, Andreas
    Simon, Perikles
    Mertens, Peter R.
    Floege, Juergen
    Luft, Friedrich
    Asante-Poku, Steven
    Schaeffeler, Elke
    Lang, Florian
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2008, 21 (1-3) : 151 - 160
  • [50] IFIH1 gene polymorphisms in type 1 diabetes: Genetic association analysis and genotype-phenotype correlation in the Belgian population
    Aminkeng, Folefac
    Van Autreve, Jan E.
    Weets, Ilse
    Quartier, Erik
    Van Schravendijk, Chris
    Gorus, Frans K.
    Van der Auwera, Bart J.
    HUMAN IMMUNOLOGY, 2009, 70 (09) : 706 - 710